@article{article, title = {{Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer鈥檚 disease: a phase 1b, randomized, placebo-controlled trial}}, publisher = {{Springer Science and Business Media LLC}}, url = {{http://dx.doi.org/10.1038/s41591-023-02326-3 }}, year = {{2023}}, month = {{4}}, author = {{Mummery CJ and B枚rjesson-Hanson A and Blackburn DJ and Vijverberg EGB and De Deyn PP and Ducharme S and Jonsson M and Schneider A and Rinne JO and Ludolph AC and Bodenschatz R et al}}, doi = {{10.1038/s41591-023-02326-3}}, journal = {{Nature Medicine}}, pages = {{1-11}}, note = {{Accessed on 2025/04/11}}}